LMH STRATEGIC SOLUTIONS

Lobbying for GLAXOSMITHKLINE LLC · Pharmaceutical Company.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jan 12, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b) program.

Pharmacy

Drug pricing issues. S.705 - Innovation in Pediatric Drugs Act of 2025. Issues related to the 340(b)program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.